MedTrace Logo

Group B Streptococcal Carrier State Prevalence Among Arab Pregnant Women in Northern Israel District

NCT02528890 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 196

Last updated 2016-04-05

No results posted yet for this study

Summary

The incidence of early neonatal GBS (group B Streptococcus) infection in the Nazareth Hospital through the years 2006-2013 has been higher compared to the national average. On reviewing all the cases of infants with early GBS infection, revealed that some of these infants were born to mothers who are not included in any of the high-risk groups that need to have prophylactic antibiotic treatment before delivery. Therefore, the question was whether pregnant Arab women in the North district of Israel have a higher GBS carrier state rate than the general rate in Israel?

Conditions

  • Streptococcus B Carrier State Complicating Pregnancy

Interventions

OTHER

vaginal/anal swab for GBS from all participants

All eligible pregnant women, who meet the inclusion criteria and gave their informed consent to participate in the study has to complete a questionnaire and have a vaginal / anal swab taken to identify positive GBS carriers by PCR (polymerase chain reaction) test.

Sponsors & Collaborators

  • The Nazareth Hospital, Israel

    lead OTHER

Principal Investigators

  • Marwan M Hakim, MD, DSc · Nazareth Hospital EMMS

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-09-30
Primary Completion
2016-03-31
Completion
2016-03-31

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02528890 on ClinicalTrials.gov